Where does OSI Pharmaceuticals, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), OSI Pharmaceuticals, LLC ranks #29,710 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does OSI Pharmaceuticals, LLC hold?

OSI Pharmaceuticals, LLC holds 9 US utility patents granted between 2015 and 2023, spanning 6 technology areas.

What is OSI Pharmaceuticals, LLC's Innovation Score?

OSI Pharmaceuticals, LLC has an Innovation Score of 39.1 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is OSI Pharmaceuticals, LLC's patent grant rate increasing or decreasing?

OSI Pharmaceuticals, LLC's recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for OSI Pharmaceuticals, LLC's patents?

OSI Pharmaceuticals, LLC's patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the OSI Pharmaceuticals, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

OSI Pharmaceuticals, LLC

Q: What technology areas does OSI Pharmaceuticals, LLC focus on?

OSI Pharmaceuticals, LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 7 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 6 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, OSI ranks #29,710 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 6 technology areas.

#29,710
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.1/100): 15.2
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29710 · US Corporation #29,710 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,710/49,997
PHOTO-FINISH Organic Construction…
CPC-NARROW A61K · 6 areas
INNOV-THIN 39.1/100
CLAIMS-RICH 15.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Organic Construction System, S.A. DE C.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Canrig Drilling… · near

39
Center of Human-Cent… · near

39
OSI Pharmaceuticals · this assignee

39
GKN Driveline North… · near

39
Tokai Kogyo · near

39
3D Lighting… · lowest

7

What this shows OSI's Innovation Score is 39.1/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where OSI's grants concentrate

OSI Pharmaceuticals, LLC is a focused PatentsView assignee: 6 CPC subclasses with 77.8% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2018. By volume, OSI sits between Organic Construction System, S.A. DE C.V. and Otto Ganter GMBH & Co. KG Normteilefabrik.

OSI's three-year grant acceleration

OSI Pharmaceuticals, LLC shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Organic Construct…

9
Oriental Yeast

9
Orkli S COOP

9
Ortus Technology

9
Osram Gesellschaf…

9
Ossio

9
Otto Bock Mobilit…

9
Otto Ganter & KG…

9
OSI Pharmaceutica… ◀

9

What this shows OSI holds 9 patents at rank #29,654, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near OSI

By rank, the assignees closest to #29,654 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in OSI's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for OSI, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Canrig Drilling Technology Ltd. 39 Center of Human-Centered Interaction for Coexistence 39 GKN Driveline North America, Inc. 39 Tokai Kogyo Co., Ltd. 39

OSI's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

OSI Pharmaceuticals, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	22.2%
2016	3	33.3%
2018	1	11.1%
2020	1	11.1%
2022	1	11.1%
2023	1	11.1%

Which technologies does OSI Pharmaceuticals, LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

C07D - Heterocyclic Compounds 3

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#29,710

of 49,997 tracked assignees

Innovation Score

39.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

OSI Pharmaceuticals, LLC's patent record in context - here's where to go next.

OSI Pharmaceuticals, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 77.8% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #29,710 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare OSI Pharmaceuticals, LLC against Organic Construction System, S.A. DE C.V., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.